TABLE 2.
Study | Disease | Treatment and Duration |
Oncological History |
Prior Immune Treatment |
Lymphopenia | CD4/8 Counts | JCV PCR | Neurological Status Iris |
MRI Manifestation |
---|---|---|---|---|---|---|---|---|---|
Ermis 201326 | Psoriasis | Fumaderm, 3 yr | None | Methotrexate 3 yr before |
Grade 3 | CD3+, CD4+ T- cell deficiency, CD4/CD8 ratio > 2 |
90 copies/ml CSF |
Progressive sensory aphasia; IRIS |
Subcortical/ juxtacortical white matter |
Van Oosten 201327 |
Psoriasis | Psorinovo, 5 yr | None | None | Grade 3 | CD3+, CD4+, CD8+ T-cell defi- ciency, CD4/CD8 ratio = 2 |
Positive | Progressive right- sided hemiparesis, IRIS |
Small, deep white matter lesions and 1 large progressive lesion |
Stoppe 201451 | Psoriasis | Fumaderm, 3 yr | Superficial malignant melanoma 3 yr before |
Efalizumab 3 yr before |
Grade 1–2 | CD4+ T-cell defi- ciency (131/µl), CD4/CD8 ratio < 2 |
>2,000 copies/ ml CSF |
Left-sided hemiataxia, dysarthria, unstable walking, no IRIS |
Lesions in the left cerebellar peduncle, hemisphere and pons (Gd+) |
Nieuwkamp 201553 |
Psoriasis | Psorinovo, 2 yr | None | None | Grade 1 | Not given | Initially negative, positive during IRIS |
Apraxia, progressive hemiparesis, somnolence, IRIS, fatal outcome |
Multiple subcortical white matter lesions (Gd+), herniation |
Rosenkranz 201528 |
Multiple sclerosis |
Tecfidera, 4.5 yr | None | Glatiramer acetate |
Grade 3 | Not given | Positive | Severe gait and speech disorder, ataxia, fatal outcome |
Confluent and progressive lesions in cerebellar peduncles, pons, and left cerebellar hemisphere |
Hoepner 201552 |
Psoriasis | Fumaderm, 4 yr | None | Toxic bone marrow damage, increased excretion of kappa light chains |
Grade 2 | Not given | 16 & 42 copies/ ml CSF |
Right hemiparesis and aphasia, IRIS |
Subcortical left hemispheric lesion |
Current study |
Psoriasis | Fumaderm, 2.5 yr | Adenocarcinoma in rectum (pT2 pN1 cM0 L0 V0) 8 yr earlier |
Adjuvant radiochemotherapy with 5-fluorouracil 8 yr earlier |
Grade 2 | CD3+, CD4+, CD8+ T-cell defi- ciency, CD4/CD8 ratio < 2 |
Negative | Diplopia, nystagmus, dysphagia, dysarthria, tetraparesis (PG 3– 4), spasticity, ataxia, IRIS |
Lesions in mesencephalon, pons, cerebellar pedunculi, and medulla oblongata (Gd+), right thalamus and subcortical lesions |
Grade 3 lymphopenia, ALC < 500; grade 2, ALC = 500–799; grade 1, ALC = 800–1,000.1 Fumaderm = 120mg dimethyl fumarate + 95mg of monoethyl fumarate); Psorinovo = dimethyl fumarate; Tecfidera = delayed-release dimethyl fumarate.
ALC = absolute lymphocyte count; CSF = cerebrospinal fluid; Gd+ = gadolinium-enhancing lesions; IRIS = immune reconstitution inflammatory syndrome; JCV = JC virus; MRI = magnetic resonance imaging; PCR = polymerase chain reaction; PG = paresis grade.